Maina Bhaman has joined Sofinnova Partners after serving as director of healthcare investment at Touchstone Innovations for over a decade.
Maina Bhaman (pictured) left Touchstone Innovations, the commercialisation firm spun out of Imperial College London, yesterday to join life sciences-focused venture capital firm Sofinnova Partners.
Bhaman has been appointed partner at Sofinnova. She previously held the position of director of healthcare investment at Touchstone since 2006.
During her time with Touchstone, she co-led a wide array of investments and took board seats at a range of UK-based biotechnology developers, such as Puridify, which was sold to GE this week.
…
